Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12,120 GBX | -0.30% | +7.54% | +14.32% |
12:52pm | Angle shares up on assay development deal with AstraZenaca | AN |
12:34pm | Angle Plc to Supply Prostate Cancer Androgen Receptor Detection Assay to AstraZeneca | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.32% | 235B | |
+29.68% | 681B | |
+19.83% | 556B | |
-4.35% | 361B | |
+17.65% | 325B | |
+3.77% | 285B | |
+4.37% | 199B | |
-11.78% | 189B | |
-3.79% | 157B | |
-3.34% | 149B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- AstraZeneca : US Regulator Extends Review Period For AstraZeneca's Anemia Drug For Kidney Disease Patients